Влияние микроорганизмов на аллергическую реактивность человека

1. Антропова А.Б. Микромицеты как источник аллергенов в жилых помещениях г. Москвы. Автореф. дис. …канд. мед. наук. 2005.
2. Ахапкина И.Г., Краханенкова С.Н., Мамленкова Е.А. и др. Частота встречаемости гиперчувствительности к грибным и клещевым аллергенам. Клин. лаб. диагностика. 2009; 7: 33–5.
3. Бабьева И.П., Чернов И.Ю. Биология дрожжей. М.: Товарищество научных изданий КМК, 2004.
4. Кашкин П.Н., Шеклаков Н.Д. Руководство по медицинской микологии. М.: Медицина, 1978.
5. Поспелова А.В., Бурмистрова А.Л., Хомич Ю.С., Самышкина Н.Е. Влияние грибов рода Candida на синтез IL-10 иммунными клетками периферической крови человека in vitro. Успехи медицинской микологии. Мат-лы 4-го Всероссийского конгресса по медицинской микологии. 2006; 8: 53–5.
6. Титов В.Н. С-реактивный белок – вектор переноса жирных кислот к клеткам, которые непосредственно реализуют синдром системного воспалительного ответа. Клин. лаб. диагностика. 2008; 6: 3–13.
7. Шевченко М.А., Шеховцова Е.Л., Алексеева Л.Г., Свирщевская Е.В. Анализ гуморального ответа при инвазивном и аллергическом аспергиллезе с использованием мышиных моделей. Успехи медицинской микологии. Мат-лы 4-го Всероссийского конгресса по медицинской микологии. 2006; 8: 63–4.
8. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782–7.
9. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675–80.
10. Almazan J, de la Fuente R, Gomez-Lucia E et al. Enterotoxin production by strains of Staphylococcus intermedius and Staphylococcus aureus isolated from dog infections. Zetralbl Bakteriol Microbial Hyg 1987; 1–2 (264): 29–32.
11. Alouf JE, Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol 2003; 7–8 (292): 429–40.
12. Bjorksten B. Evidence of probiotics in prevention of allergy and asthma. Curr Drug Targets Inflamm Allergy 2005; 5 (4): 599–604.
13. Breuer K, Wittmann M, Bosche B et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000; 6 (55): 551–5.
14. Buslau M, Kappus R, Gerlach D et al. Streptococcal and staphylococcal superantigens (ETA, SEB): presentation by human epidermal cell and induction of autologious T-cell proliferation in vitro. Acta Derm Venerol (Stockh) 1993; 73: 94–6.
15. al-Daccak R, Mehindate K, Hebert J et al Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immune 1994; 6 (62): 2409–16.
16. Devore-Carter D, Kar S, Vellucci V et al. Superantigen-like effects of a Candida albicans polypeptide. J Infec Dis 2008; 197 (7, V. 1): 981–9.
17. Eisenbarth SC, Piggott DA, Huleatt JW et al. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exper Med 2002; 12 (196): 1645–51.
18. Gjertsson I, Foster S, Tarkowski A. Polarization of cytokine response in B- and T-lymphocytes during staphylococcus aureus infection. Microb Pathog 2003; 3 (35): 119–24.
19. Hachiya O, Takeda Y, Miyata H et al. Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro. Microbiol Immunol 1995; 9 (39): 715–23.
20. Hessle C, Andersson B, Wold E. Gram-positive Bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-ne­gative Bacteria preferentially stimulated IL-10 production. Infect Immunity 2000; 6 (68): 3581–6.
21. Instanes C, Ormstad H, Rydjord B et al. Mould extracts increase the allergic response to ovalbumin in mice. Clin Exp Allergy 2004; 10 (34): 1634–41.
22. Kang TJ, Le SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002; 20: 56–62.
23. Kopp MV, Semmler S, Ihorst G et al. Hospital admission with neonatal sepsis and development of atopic disease: Is there a link? Pediatr Allergy Immunol 2005; 8 (16): 630–6.
24. Lee A, Whyte MKB, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993; 54: 283–8.
25. Lee JY, Seo JH, Kwon JW et al. Exposure to gene-environment interections before 1 year of age may favor the development of atopic dermatitis. Int Arch Allergy Immunol 2011; 4 (157): 363–71.
26. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001; 167: 527 8–85.
27. von Matius E, Braun-Fahrlander C, Schierl R et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000; 9 (30): 1230–4.
28. Murray DA, Wilton MA. Lipopolysaccharide from the periodontal pathogen Porphyromonas gingivalis prevents apoptosis of HL60-derived neutrophils in vitro. Infect Immun 2003; 12 (71): 7232–5.
29. Netea MG, van Deuren M, Kullberg BJ et al. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends in Immunology 2002; 3 (23): 15–139.
30. Neuber K, Konig W. Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expressionin patients with atopic dermatitis. Immunology 1992; 1 (75): 23–8.
31. Ohmen JD, Barnes PF, Grisso CL et al. Evidence for a superantigen in human tuberculosis. Immunity 1994; 1; 35–43.
32. Onishi N, Kawamoto Seiji, Ueda K et al. Dietary pulverized konjac glucomannan prevents the development of allergic rhinitis-like symptoms and IgE response in mice. Biosc Biotechnol Biochem 2007; 10 (71): 2551–6.
33. Platts-Mills TAE, Woodfolk JA, Sporik RB. The increase in asthma cannot be ascribed to cleanliness. Am J Respir Care Med 2001; 7 (164): 1107–8.
34. Prioult G, Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack microbial stimulation? Immunol Rew 2005; 1 (206): 204–18.
35. Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid. Biosci Biotechnol Biochem 2007; 10 (71): 2428–34.
36. Schram-Bijkerk D, Doekes G, Boeve M et al. Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin & Exp Allergy 2005; 35: 1272–8.
37. Sepp E, Julge K, Mikelsaar M et al. Intestinal microbiota and immunoglobulin E responses in 5-year-ld Estonian children. Clin & Exp Allergy 2005; 35: 1141–6.
38. Tanaka H, Abe S, Tamura H. Pathological changes by the imba­lance of host T helper lymphocyte subset in Mycoplasma pulmonis pneumonia of mice. Kansenshogaku Zasshi 1998; 4 (72): 342–6.
39. Trujillo C, Erb KJ. Inhibition of allergic disorders by infection with bacteria or the exposure to bacterial products. Int J Med Microbiol 2003; 2–3 (293): 123–31.
40. Tulic MK, Fiset PO, Manoukian JJ et al. Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004; 363: 1689–97.
41. Werner M, Topp R, Wmmer K et al. TLR-4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003; 112: 323–30.
42. Williams LK, Ownby DR, Maliarik MJ et al. The role of endotoxin and its receptors in allergic disease. Ann Allergy Asthma Immunol 2005; 3 (94): 323–32.

И.Г.Ахапкина

ФГБУ Научно-исследовательский институт вакцин и сывороток им. И.И.Мечникова РАМН, Москва